Thermo Fisher Scientific Inc.
TMO
$402.82
-$0.93-0.23%
NYSE
| 03/29/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.05% | 7.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.05% | 7.52% | |||
| Cost of Revenue | -6.61% | 4.63% | |||
| Gross Profit | -12.35% | 11.69% | |||
| SG&A Expenses | -5.28% | 4.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.68% | 5.18% | |||
| Operating Income | -18.62% | 18.13% | |||
| Income Before Tax | -18.64% | 14.17% | |||
| Income Tax Expenses | -36.67% | 51.52% | |||
| Earnings from Continuing Operations | -17.16% | 11.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -166.67% | -- | |||
| Net Income | -17.65% | 12.27% | |||
| EBIT | -18.62% | 18.13% | |||
| EBITDA | -15.39% | 13.60% | |||
| EPS Basic | -16.78% | 12.27% | |||
| Normalized Basic EPS | -21.37% | 22.38% | |||
| EPS Diluted | -16.74% | 12.47% | |||
| Normalized Diluted EPS | -21.37% | 22.70% | |||
| Average Basic Shares Outstanding | -1.05% | 0.00% | |||
| Average Diluted Shares Outstanding | -1.04% | -0.26% | |||
| Dividend Per Share | 10.26% | 0.00% | |||
| Payout Ratio | 0.21% | -0.12% | |||